Improvement in Glycemic Control of Type 2 Diabetes After Successful Treatment of Hepatitis C Virus.

Justine HumJanice H JouPamela K GreenKristin BerryJames LundbladBarbara D HettingerMichael ChangGeorge N Ioannou

Published in: Diabetes care (2017)

DAA-based eradication of HCV is associated with improved glycemic control in patients with diabetes as evidenced by decreased mean HbA1c and decreased insulin use. These endocrine benefits of SVR provide additional justification for considering antiviral treatment in all patients with diabetes.

Keyphrases

glycemic control
hepatitis c virus
type diabetes
blood glucose
human immunodeficiency virus
weight loss
insulin resistance
cardiovascular disease
helicobacter pylori infection
replacement therapy